Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, we identified people who were prescribed a GLP-1 RA between January 01, 2018 and December 31, 2023
There are also other practical reasons to prescribe these drugs in people with type 2 diabetes, because all three classes are associated with relatively low risk of hypoglycemic events, while patients treated with GLP-1RA and SGLT-2 inhibitors may also benefit from weight loss [11]
DAPA-CKD, Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease
Hepatol Res
Jastreboff AM, Kaplan LM, Fras JP, Wu Q, Du Y, Gurbuz S, et al
Heres why we chose the specific ingredients in the formula